Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...

The Hauptman-Woodward Medical Research Institute on the Buffalo Niagara Medical Campus is now officially part of the ...

Despite concerns over immigration and tariff policies, Chamber of Commerce members expressed optimism that forces like AI, tourism and life sciences will keep companies strong.

Luckily, this won't happen until at least 1.6 billion years from now, suggests new research from University of Chicago ...

LAS VEGAS — With CES 2025 in full swing, hundreds of innovators, engineers and manufacturers have descended on Las Vegas to ...

MI-HQ will anchor Dan Gilbert’s Bedrock development at the former “fail jail” site on Gratiot Avenue in downtown Detroit with ...

Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies that detect diseases at different stages of progression.

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Evolution is often depicted as a steady forward march from simple to complex forms. But new research shows that certain ferns ...